drugset / Trial / NCT02018887

A Study of LY2969822 in Healthy Participants

NCT02018887 ↗

Phase 1 Completed 99 enrolled Eli Lilly and Company
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to evaluate how safe LY2969822 (study drug) is and whether it causes any side effects. The study will also measure how much of the study drug gets into the blood stream and how long it takes the body to get rid of the study drug. This is the first time that this study drug is being given to participants. This study is for research purposes only and is not intended to treat any medical condition.

Timeline

Start
2013-12
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject LY2969822 Unknown — Oral

Indications

No indication recorded.